Literature DB >> 12367785

Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood.

Caroline Alby, Ouardia Ben Abdesselam, Marie-José Foglietti, Jean-Louis Beaudeux.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 12367785     DOI： 10.1016/s0009-8981(02)00247-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  3 in total

1.  The Use of Serum MMP-9 and TIMP-1 in Acute Coronary Syndrome.

Authors:  Laura Lahdentausta; Timo Sorsa; Erkki Pesonen; Pirkko Pussinen
Journal:  J Cardiovasc Transl Res       Date:  2018-09-24       Impact factor: 4.132

2.  Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.

Authors:  N El Houda Agueznay; C Badoual; S Hans; A Gey; B Vingert; S Peyrard; F Quintin-Colonna; P Ravel; P Bruneval; S Roncelin; B Lelongt; J Bertoglio; W H Fridman; D Brasnu; E Tartour
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

3.  Levels of matrix metalloproteinases differ in plasma and serum - aspects regarding analysis of biological markers in cancer.

Authors:  Andreas Jonsson; Claes Hjalmarsson; Peter Falk; Marie-Lois Ivarsson
Journal:  Br J Cancer       Date:  2016-05-17       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.